Epigenomics AG NA buy matumba
Start price
30.01.11
/
50%
€8.49
Target price
01.08.11
€11.00
Performance (%)
-27.52%
End price
01.08.11
€6.15
Summary
This prediction ended on 01.08.11 with a price of €6.15. The price of Epigenomics AG NA has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -27.52%. matumba has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Epigenomics AG NA | - | - | - | - |
| iShares Core DAX® | -0.922% | -1.993% | 13.399% | 16.075% |
| iShares Nasdaq 100 | 0.371% | -0.868% | 41.541% | 46.938% |
| iShares Nikkei 225® | 2.224% | -5.187% | 20.497% | 4.643% |
| iShares S&P 500 | -0.026% | -0.918% | 30.410% | 42.418% |
Comments by matumba for this prediction
In the thread Epigenomics AG NA diskutieren
einsteigen
ich tat mir anfangs schwer, halte aber die aktien seit längeren,
jetzt kaufe ich sogar nach:
Epigenomics künftiger CFO überzeugt genauso wie Epi ProColon 2.0
Mannheim (aktiencheck.de AG) - Thomas Schießle, Analyst von MIDAS Research,
stuft die Aktie von Epigenomics (ISIN DE000A0BVT96/ WKN A0BVT9) unverändert mit dem Rating "langfristig kaufen" ein. Das neu...
(Laufzeit überschritten)